Nobel winner signs deal
Source: Xinhua |
November 4, 2012, Sunday
|
Print Edition
Print Edition
NOBEL laureate Martin Evans yesterday signed an agreement on conducting stem cell anti-aging research with Zhongyuan Union Stem Cell Bio-engineering Corporation in north China's Tianjin Municipality.
Evans was awarded the Nobel Prize in Physiology or Medicine in 2007 and co-established Cell Therapy Ltd (CTL), a biological high-tech enterprise undertaking stem cell research and clinical application, in Wales.
Under the agreement, domestic life science and technology enterprise Zhongyuan and CTL will jointly invest US$8 million to create a new company this year in Tianjin. This will industrialize achievements from research.
The prospects for anti-aging research on stem cells are "brilliant," said Evans.
Evans was awarded the Nobel Prize in Physiology or Medicine in 2007 and co-established Cell Therapy Ltd (CTL), a biological high-tech enterprise undertaking stem cell research and clinical application, in Wales.
Under the agreement, domestic life science and technology enterprise Zhongyuan and CTL will jointly invest US$8 million to create a new company this year in Tianjin. This will industrialize achievements from research.
The prospects for anti-aging research on stem cells are "brilliant," said Evans.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
